US Peripheral Nerve Injuries Market To Witness Rapid Development

U.S. Peripheral Nerve Injuries Industry Overview

The U.S. peripheral nerve injuries market was valued at USD 465.0 million in 2024 and is projected to expand at a CAGR of 7.4% from 2025 to 2030. This robust growth is driven by several factors, including technological advancements in surgical techniques, the rising popularity of minimally invasive procedures, and an increasing geriatric population, which is more susceptible to such injuries. The aging process slows the regeneration of the peripheral nervous system (PNS), making older adults particularly vulnerable. According to a research study published by Merck & Co., Inc., the regenerative capacity of the PNS diminishes with age, exacerbating the risk of injuries and related complications. Furthermore, a January 2024 article by the Population Reference Bureau (PRB) highlights that the number of people aged 65 and older in the U.S. is expected to grow significantly, from 58 million in 2022 to 82 million by 2050, adding to the demand for effective treatments for peripheral nerve injuries.

Another contributing factor is the growing inclination toward driving and the resulting rise in motor vehicle accidents, which are a major cause of peripheral nerve injuries. According to an August 2023 research article published by the National Library of Medicine, motor vehicle crashes accounted for 46% of all peripheral nerve injuries. This trend underscores the need for advanced medical solutions to address these injuries. Additionally, the increasing incidence of traumatic injuries from sports activities, workplace accidents, and daily physical activities further fuels the demand for treatment. These injuries often result in nerve damage, driving the need for innovative therapeutic options and contributing to market growth.

As the market evolves, the combination of an aging population, advancements in surgical technology, and rising injury rates across various demographics is expected to create substantial opportunities for stakeholders in the U.S. peripheral nerve injuries market.

Gather more insights about the market drivers, restrains and growth of the U.S. Peripheral Nerve Injuries Market

End-use Insights:

Hospitals:

Accounted for the largest market share of 60.0% in 2024, solidifying their position as primary centers for diagnosing, treating, and managing health issues, including peripheral nerve injuries.
Key growth drivers include:

The high volume of surgical procedures performed in hospital settings.
Continuous advancements in medical technologies, enabling hospitals to offer state-of-the-art treatments.
Rising patient preference for specialized care, which hospitals are well-equipped to provide.

The increasing number of hospitals and their enhanced accessibility further contribute to this segment's growth.

Example: According to the American Hospital Association (AHA) data for 2024, there were 6,120 hospitals in the U.S., underscoring the availability of healthcare infrastructure to support patient needs.

Ambulatory Surgical Centers (ASCs):

Expected to grow at the fastest CAGR of 8.4% during the forecast period.
Growth is driven by their ability to offer:

Specialized, minimally invasive procedures, which are less complex and allow for quicker recovery times compared to traditional hospital treatments.
Cost-effective and efficient treatments, meeting the demands of patients seeking affordable healthcare solutions.

Increasing focus on same-day discharge procedures aligns with the preference for shorter hospital stays, further boosting the popularity of ASCs.

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global biomaterials market size was estimated at USD 178.0 billion in 2023 and is projected to grow at a CAGR of 15.6% from 2024 to 2030.
The global stem cell therapy market size was estimated at USD 386.7 million in 2023 and is expected to grow at a CAGR of 24.15% from 2024 to 2030.

Key U.S. Peripheral Nerve Injuries Company Insights

Some of the key companies operating in the U.S. peripheral nerve injury market include Axogen Corporation., Stryker, Regenity, and Integra LifeSciences Corporation. These companies engaged in various strategies to increase their market share. This includes techniques such as developing new and innovative products, mergers and acquisitions, and expansion activities.

Axogen Corporation is a medical technology company that develops and commercializes surgical nerve repair and regeneration solutions. It addresses peripheral nerve injuries, including those resulting from trauma, tumor resections, and other surgical procedures. The company offers a range of products designed to support nerve regeneration, such as Avance Nerve Graft, a human nerve allograft that can help regenerate damaged nerves.
Stryker is a global company that develops a wide range of products and services in orthopedic, surgical, neurotechnology, and spine specialties. The company's peripheral nerve portfolio consists of type I collagen conduits and wrap.

Key U.S. Peripheral Nerve Injuries Companies: